Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 11 | 2021 | 118 | 1.820 |
Why?
|
| Interpeduncular Nucleus | 8 | 2024 | 21 | 1.580 |
Why?
|
| Ventral Tegmental Area | 10 | 2023 | 38 | 1.370 |
Why?
|
| Receptors, Nicotinic | 13 | 2016 | 69 | 1.340 |
Why?
|
| Nicotinic Agonists | 7 | 2017 | 39 | 1.100 |
Why?
|
| Substance Withdrawal Syndrome | 5 | 2021 | 124 | 0.870 |
Why?
|
| GABAergic Neurons | 6 | 2025 | 38 | 0.870 |
Why?
|
| Dopamine | 8 | 2024 | 108 | 0.870 |
Why?
|
| Habenula | 4 | 2020 | 15 | 0.850 |
Why?
|
| Anxiety | 6 | 2025 | 438 | 0.600 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2016 | 38 | 0.480 |
Why?
|
| Mice, Inbred C57BL | 14 | 2025 | 3482 | 0.420 |
Why?
|
| Mice | 22 | 2025 | 11215 | 0.380 |
Why?
|
| Dopaminergic Neurons | 5 | 2023 | 38 | 0.360 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2009 | 22 | 0.310 |
Why?
|
| Parkinsonian Disorders | 1 | 2009 | 15 | 0.310 |
Why?
|
| Neurons | 4 | 2012 | 949 | 0.300 |
Why?
|
| Animals | 23 | 2025 | 21529 | 0.290 |
Why?
|
| Reward | 4 | 2023 | 89 | 0.270 |
Why?
|
| Mecamylamine | 4 | 2021 | 14 | 0.250 |
Why?
|
| Ethanol | 4 | 2013 | 330 | 0.230 |
Why?
|
| Nerve Net | 2 | 2017 | 101 | 0.230 |
Why?
|
| Nicotinic Antagonists | 3 | 2013 | 19 | 0.210 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 1310 | 0.170 |
Why?
|
| Motivation | 1 | 2023 | 295 | 0.170 |
Why?
|
| MicroRNAs | 2 | 2020 | 710 | 0.170 |
Why?
|
| Male | 14 | 2025 | 31073 | 0.160 |
Why?
|
| Somatostatin | 2 | 2025 | 21 | 0.160 |
Why?
|
| RNA, Messenger | 2 | 2020 | 1580 | 0.160 |
Why?
|
| Corpus Striatum | 1 | 2019 | 98 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 43 | 0.140 |
Why?
|
| Synaptic Transmission | 2 | 2024 | 152 | 0.140 |
Why?
|
| Cocaine | 1 | 2019 | 101 | 0.140 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2015 | 35 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2019 | 211 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2015 | 55 | 0.130 |
Why?
|
| Action Potentials | 3 | 2015 | 112 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2017 | 3157 | 0.130 |
Why?
|
| Exploratory Behavior | 1 | 2017 | 37 | 0.130 |
Why?
|
| Xenobiotics | 1 | 2017 | 13 | 0.130 |
Why?
|
| Paternal Exposure | 1 | 2017 | 6 | 0.130 |
Why?
|
| Paternal Inheritance | 1 | 2017 | 7 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2017 | 85 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2019 | 421 | 0.120 |
Why?
|
| Cholinergic Neurons | 1 | 2016 | 10 | 0.120 |
Why?
|
| Protein Subunits | 2 | 2013 | 166 | 0.110 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 27 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2016 | 2162 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2017 | 222 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 201 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 245 | 0.110 |
Why?
|
| Ion Channels | 1 | 2014 | 93 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 379 | 0.100 |
Why?
|
| Rhodopsin | 1 | 2013 | 15 | 0.100 |
Why?
|
| Phototherapy | 1 | 2013 | 36 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 432 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 252 | 0.100 |
Why?
|
| Acetylcholine | 2 | 2012 | 48 | 0.100 |
Why?
|
| Mesencephalon | 2 | 2025 | 28 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2013 | 103 | 0.100 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 90 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2011 | 612 | 0.100 |
Why?
|
| Light | 1 | 2013 | 206 | 0.100 |
Why?
|
| Optogenetics | 2 | 2025 | 32 | 0.090 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2011 | 3 | 0.090 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bicuculline | 1 | 2011 | 6 | 0.090 |
Why?
|
| Microdissection | 1 | 2011 | 7 | 0.090 |
Why?
|
| Atropine | 1 | 2011 | 13 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 38 | 0.080 |
Why?
|
| Cell Size | 1 | 2011 | 41 | 0.080 |
Why?
|
| Cell Count | 1 | 2011 | 133 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 133 | 0.080 |
Why?
|
| Muscarinic Antagonists | 1 | 2011 | 34 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2011 | 140 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2011 | 127 | 0.080 |
Why?
|
| Benzazepines | 1 | 2010 | 21 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 1635 | 0.080 |
Why?
|
| Quinoxalines | 1 | 2010 | 37 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 495 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 882 | 0.080 |
Why?
|
| Catalepsy | 1 | 2009 | 3 | 0.080 |
Why?
|
| Cholinergic Fibers | 1 | 2009 | 4 | 0.080 |
Why?
|
| Quinpirole | 1 | 2009 | 5 | 0.080 |
Why?
|
| Muscle Rigidity | 1 | 2009 | 7 | 0.080 |
Why?
|
| Epilepsy, Generalized | 1 | 2009 | 5 | 0.080 |
Why?
|
| Dopamine Agonists | 1 | 2009 | 22 | 0.080 |
Why?
|
| Temperature | 1 | 2011 | 316 | 0.080 |
Why?
|
| Interneurons | 1 | 2009 | 22 | 0.080 |
Why?
|
| Multigene Family | 1 | 2010 | 106 | 0.080 |
Why?
|
| Tremor | 1 | 2009 | 26 | 0.080 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 27 | 0.070 |
Why?
|
| Carcinoma | 1 | 2010 | 130 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 303 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 240 | 0.070 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 70 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 322 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 712 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 743 | 0.060 |
Why?
|
| Avoidance Learning | 1 | 2025 | 27 | 0.060 |
Why?
|
| Fear | 1 | 2025 | 71 | 0.060 |
Why?
|
| Tegmentum Mesencephali | 1 | 2024 | 6 | 0.050 |
Why?
|
| Sucrose | 1 | 2023 | 29 | 0.050 |
Why?
|
| Learning | 1 | 2025 | 185 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 720 | 0.050 |
Why?
|
| Nucleus Accumbens | 1 | 2023 | 47 | 0.050 |
Why?
|
| Profilins | 1 | 2020 | 45 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 207 | 0.040 |
Why?
|
| Locomotion | 1 | 2019 | 117 | 0.040 |
Why?
|
| Dopamine Antagonists | 1 | 2017 | 16 | 0.030 |
Why?
|
| Maze Learning | 1 | 2017 | 56 | 0.030 |
Why?
|
| Inactivation, Metabolic | 1 | 2017 | 14 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 629 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 800 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2017 | 156 | 0.030 |
Why?
|
| Calbindin 2 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Calbindins | 1 | 2015 | 10 | 0.030 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2015 | 4 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 591 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2015 | 22 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 2015 | 27 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 132 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2211 | 0.030 |
Why?
|
| Mutation | 2 | 2015 | 2679 | 0.030 |
Why?
|
| Emotions | 1 | 2016 | 229 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 96 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 199 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 421 | 0.020 |
Why?
|
| Mammals | 1 | 2014 | 224 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 48 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 146 | 0.020 |
Why?
|
| Female | 2 | 2017 | 34125 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 879 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 2010 | 9 | 0.020 |
Why?
|
| Varenicline | 1 | 2010 | 11 | 0.020 |
Why?
|
| Alanine | 1 | 2010 | 51 | 0.020 |
Why?
|
| Leucine | 1 | 2010 | 67 | 0.020 |
Why?
|
| Central Nervous System Depressants | 1 | 2010 | 46 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 171 | 0.020 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2010 | 18 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 784 | 0.020 |
Why?
|
| Darkness | 1 | 2009 | 23 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 198 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 930 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 697 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 906 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 593 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 1606 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1611 | 0.010 |
Why?
|
| Smoking | 1 | 2010 | 866 | 0.010 |
Why?
|
| Humans | 3 | 2019 | 65528 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2283 | 0.010 |
Why?
|